Whole blood, as one of the most significant biological fluids, provides critical information for
health management and disease monitoring. Over the past 10 years, advances in …

It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

PREAMBLE Our mission was to develop evidence-based guidelines for the prevention and
treatment of perioperative/postoperative atrial fibrillation and flutter (POAF) for thoracic …

Heart failure (HF) is a major and growing public health problem in the United States.
Approximately 5 million patients in this country have HF, and over 550 000 patients are …

Heart failure resulting in hospitalization represents a significant and growing health care
burden. Heterogeneity characterizes this group in terms of mode of presentation …

Background—About half of the 5 million heart failure patients in the United States have
diastolic heart failure (clinical heart failure with normal or near-normal ejection fraction) …

Aims Digoxin is frequently used for rate control of atrial fibrillation (AF). It has, however, been
associated with increased mortality. It remains unclear whether digoxin itself is responsible …

Chronic heart failure (CHF) remains the only cardiovascular disease with an increasing
hospitalization burden and an ongoing drain on health care expenditures. The prevalence of …

Aims ACE‐inhibitors, β‐blockers, implantable cardioverter–defibrillator (ICD) and cardiac
resynchronization therapy (CRT) improved prognosis of heart failure. We sought to analyse …

Aims To determine the effects of digoxin on all-cause mortality and heart failure (HF)
hospitalizations, regardless of ejection fraction, accounting for serum digoxin concentration …